Chiari Malformation Type 2

Search Trials
Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound
Status:
Not yet recruiting
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Ultrasound Therapy; Complications
Intervention(s):
Therapeutic Ultrasound
Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 2, 2010
Disease(s):
Healthy Volunteers
Intervention(s):
Rotigotine transdermal patch
Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Apr 1, 2013
Disease(s):
Healthy
Intervention(s):
Rotigotine transdermal patch
Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis
Status:
Completed
Last Changed:
Jan 1, 1970
First Changed:
Jan 1, 1970
Disease(s):
Actinic Keratosis
Intervention(s):
Ingenol mebutate gelplacebo
A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis
Status:
Completed
Last Changed:
Nov 11, 2015
First Changed:
Jan 1, 1970
Disease(s):
Actinic Keratosis
Intervention(s):
LEO 43204 Formulation 1LEO 43204 Formulation 2LEO 43204 Formulation 1 Dose XLEO 43204 Formulation 1 Dose YLEO 43204 Formulation 2 Dose XXLEO 43204 Formulation 2 Dose YYPlacebo Formulation 1Placebo Formulation 2

Connect. Empower. Inspire.